z-logo
Premium
Synthesis, characterization and in vitro antitumor activity of some arylantimony ferrocenecarboxylates and crystal structures of C 5 H 5 FeC 5 H 4 CO 2 SbPh 4 and (C 5 H 5 FeC 5 H 4 CO 2 ) 2 Sb(4‐CH 3 C 6 H 4 ) 3
Author(s) -
Liu RunChang,
Ma YongQiang,
Yu Lin,
Li JinShan,
Cui JingRong,
Wang RuiQing
Publication year - 2003
Publication title -
applied organometallic chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.53
H-Index - 71
eISSN - 1099-0739
pISSN - 0268-2605
DOI - 10.1002/aoc.491
Subject(s) - chemistry , hela , stereochemistry , crystal structure , in vitro , x ray crystallography , crystallography , diffraction , biochemistry , physics , optics
A series of arylantimony ferrocenecarboxylates with the formula (C 5 H 5 FeC 5 H 4 CO 2 ) n SbAr (5− n ) ( n = 1, 2; Ar = C 6 H 5 , 4‐CH 3 C 6 H 4 , 3‐CH 3 C 6 H 4 , 2‐CH 3 C 6 H 4 , 4‐ClC 6 H 4 , 4‐FC 6 H 4 ) were synthesized and characterized by elemental analysis, IR, 1 H NMR and mass spectra. The crystal structures of (C 5 H 5 FeC 5 H 4 CO 2 ) 2 Sb(4‐CH 3 C 6 H 4 ) 3 and C 5 H 5 FeC 5 H 4 CO 2 SbPh 4 were determined by X‐ray diffraction. Four human neoplastic cell lines (HL‐60, Bel‐7402, KB and Hela) were used to screen these compounds. The results indicate that these compounds at 10 µ M show certain in vitro antitumor activities. Copyright © 2003 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom